In the context of diabetes, however, activation of AMPK-mediated cardioprotective signaling has been shown to inhibit rather than promote pathological mitochondrial fission by altering Drp1 phosphorylation at Ser-637 [70]. Here, DNM1L is linked to diabetes mellitus.